Sector: Health Care
Director information for SUMMIT THERAPEUTICS INC
Board as disclosed in the proxy statement filed April 17, 2026. Titles and roles are as stated in that filing and may have changed since.
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Alessandra Cesano | Chief Medical Officer of ESSA Pharma; Director | 65 | [] | [] | 2026 |
| Jeff Huber | Co-founder and Managing Director of Triatomic Capital Private L.P. | 57 | [] | [] | 2026 |
| Kenneth A. Clark | Member of Wilson Sonsini Goodrich & Rosati, P.C.; Partner, TCG Labs Management, L.P.; Lead Independent Director | 67 | [] | [] | 2026 |
| Mahkam Zanganeh | Co-Chief Executive Officer, President & Director of Summit Therapeutics Inc.; Founder and Chief Executive Officer of Maky Zanganeh and Associates | 55 | [] | [] | 2026 |
| Manmeet S. Soni | Chief Operating Officer, Chief Financial Officer and Director of Summit Therapeutics Inc. | 48 | [] | [] | 2026 |
| Mostafa Ronaghi | Co-Founder and Executive Board Member of Cellanome; Director | 57 | [] | [] | 2026 |
| Robert Booth | Retired Executive and Professor; Board Member; Director | 72 | [] | [] | 2026 |
| Robert W. Duggan | Co-Chief Executive Officer & Chairman of the Board of Directors of Summit Therapeutics Inc.; Chief Executive Officer of Duggan Investments, Inc. | 81 | [] | [] | 2026 |
| Yu (Michelle) Xia | Chief Executive Officer and Chairwoman of Akeso, Inc.; Director | 59 | [] | [] | 2026 |
